Compounds > etoposide
Page last updated: 2024-08-23

etoposide and Arteriovenous Malformations

etoposide has been researched along with Arteriovenous Malformations in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Braga, A; Mattar, R; Passos, JP; Signorini Filho, RC; Silva, ACBD; Sun, SY1
Barber, JT; Goodman, JD; Martinez, FJ; Peisner, DB; Taboada, CD; Tressler, TB; Willis, GS1

Other Studies

2 other study(ies) available for etoposide and Arteriovenous Malformations

ArticleYear
Uterine Rescue in High-Risk Gestational Trophoblastic Neoplasia Treated with EMA-CO by Uterine Arteries Embolization due to Arteriovenous Malformations.
    Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia, 2021, Volume: 43, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Arteriovenous Malformations; Cyclophosphamide; Dactinomycin; Embolization, Therapeutic; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Pregnancy; Pregnancy, High-Risk; Ultrasonography, Prenatal; Uterine Artery; Uterine Hemorrhage; Vincristine; Young Adult

2021
Arteriovenous malformation identification after conservative management of placenta percreta with uterine artery embolization and adjunctive therapy.
    American journal of obstetrics and gynecology, 2011, Volume: 204, Issue:5

    Topics: Adult; Antineoplastic Agents, Phytogenic; Arteriovenous Malformations; Cesarean Section; Etoposide; Female; Humans; Hysterectomy; Placenta Accreta; Postpartum Hemorrhage; Pregnancy; Treatment Outcome; Uterine Artery Embolization

2011